These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cytochrome P450 CYP2D6. Wolf CR; Smith G IARC Sci Publ; 1999; (148):209-29. PubMed ID: 10493260 [TBL] [Abstract][Full Text] [Related]
23. Variation of gene-based SNPs and linkage disequilibrium patterns in the human genome. Tsunoda T; Lathrop GM; Sekine A; Yamada R; Takahashi A; Ohnishi Y; Tanaka T; Nakamura Y Hum Mol Genet; 2004 Aug; 13(15):1623-32. PubMed ID: 15190013 [TBL] [Abstract][Full Text] [Related]
24. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Hawi Z; Lowe N; Kirley A; Gruenhage F; Nöthen M; Greenwood T; Kelsoe J; Fitzgerald M; Gill M Mol Psychiatry; 2003 Mar; 8(3):299-308. PubMed ID: 12660802 [TBL] [Abstract][Full Text] [Related]
25. [CYP2D6 gene polymorphism in psychiatric patients resistant to standard pharmacotherapy]. Zabrocka M; Woszczek G; Borowiec M; Rabe-Jabłońska J; Kowalski ML Psychiatr Pol; 1999; 33(1):91-100. PubMed ID: 10786218 [TBL] [Abstract][Full Text] [Related]
26. Selecting predictive markers for pharmacogenetic traits: tagging vs. data-mining approaches. Sabbagh A; Génin E; Darlu P Hum Hered; 2008; 66(1):10-8. PubMed ID: 18223313 [TBL] [Abstract][Full Text] [Related]
27. Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity. Wang D; Poi MJ; Sun X; Gaedigk A; Leeder JS; Sadee W Hum Mol Genet; 2014 Jan; 23(1):268-78. PubMed ID: 23985325 [TBL] [Abstract][Full Text] [Related]
28. Data-mining methods as useful tools for predicting individual drug response: application to CYP2D6 data. Sabbagh A; Darlu P Hum Hered; 2006; 62(3):119-34. PubMed ID: 17057402 [TBL] [Abstract][Full Text] [Related]
29. Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations. Jorge LF; Eichelbaum M; Griese EU; Inaba T; Arias TD Pharmacogenetics; 1999 Apr; 9(2):217-28. PubMed ID: 10376769 [TBL] [Abstract][Full Text] [Related]
30. Whole genome association mapping by incompatibilities and local perfect phylogenies. Mailund T; Besenbacher S; Schierup MH BMC Bioinformatics; 2006 Oct; 7():454. PubMed ID: 17042942 [TBL] [Abstract][Full Text] [Related]
31. Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican Mestizos. Contreras AV; Monge-Cazares T; Alfaro-Ruiz L; Hernandez-Morales S; Miranda-Ortiz H; Carrillo-Sanchez K; Jimenez-Sanchez G; Silva-Zolezzi I Pharmacogenomics; 2011 May; 12(5):745-56. PubMed ID: 21391885 [TBL] [Abstract][Full Text] [Related]
32. Contrasting linkage-disequilibrium patterns between cases and controls as a novel association-mapping method. Zaykin DV; Meng Z; Ehm MG Am J Hum Genet; 2006 May; 78(5):737-746. PubMed ID: 16642430 [TBL] [Abstract][Full Text] [Related]
33. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region. Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096 [TBL] [Abstract][Full Text] [Related]
34. The effect of missing data on linkage disequilibrium mapping and haplotype association analysis in the GAW14 simulated datasets. McCaskie PA; Carter KW; McCaskie SR; Palmer LJ BMC Genet; 2005 Dec; 6 Suppl 1(Suppl 1):S151. PubMed ID: 16451612 [TBL] [Abstract][Full Text] [Related]
36. Linkage disequilibrium and association mapping: an introduction. Collins AR Methods Mol Biol; 2007; 376():1-15. PubMed ID: 17984534 [TBL] [Abstract][Full Text] [Related]
37. Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization. Hicks JK; Swen JJ; Gaedigk A Curr Drug Metab; 2014 Feb; 15(2):218-32. PubMed ID: 24524666 [TBL] [Abstract][Full Text] [Related]
38. Recent examples on the clinical relevance of the CYP2D6 polymorphism and endogenous functionality of CYP2D6. Haertter S Drug Metabol Drug Interact; 2013; 28(4):209-16. PubMed ID: 24088607 [TBL] [Abstract][Full Text] [Related]
39. Similarities and/or dissimilarities of CYP2D6 polymorphism in three Tunisian ethnic groups: Arabs, Berbers, Numides. Attitallah S; Berard M; Belkahia C; Bechtel YC; Bechtel PR Therapie; 2000; 55(3):355-60. PubMed ID: 10967712 [TBL] [Abstract][Full Text] [Related]
40. The extent of linkage disequilibrium in four populations with distinct demographic histories. Dunning AM; Durocher F; Healey CS; Teare MD; McBride SE; Carlomagno F; Xu CF; Dawson E; Rhodes S; Ueda S; Lai E; Luben RN; Van Rensburg EJ; Mannermaa A; Kataja V; Rennart G; Dunham I; Purvis I; Easton D; Ponder BA Am J Hum Genet; 2000 Dec; 67(6):1544-54. PubMed ID: 11078480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]